BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 28283746)

  • 1. Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve.
    Gonska B; Seeger J; Keßler M; von Keil A; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2017 Aug; 106(8):590-597. PubMed ID: 28283746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement With the SAPIEN 3.
    Mauri V; Reimann A; Stern D; Scherner M; Kuhn E; Rudolph V; Rosenkranz S; Eghbalzadeh K; Friedrichs K; Wahlers T; Baldus S; Madershahian N; Rudolph TK
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2200-2209. PubMed ID: 27832845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of permanent pacemaker implantation after transfemoral aortic valve implantation with the Lotus valve.
    Keßler M; Gonska B; Seeger J; Rottbauer W; Wöhrle J
    Am Heart J; 2017 Oct; 192():57-63. PubMed ID: 28938964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.
    Maeno Y; Abramowitz Y; Kawamori H; Kazuno Y; Kubo S; Takahashi N; Mangat G; Okuyama K; Kashif M; Chakravarty T; Nakamura M; Cheng W; Friedman J; Berman D; Makkar RR; Jilaihawi H
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1139-1147. PubMed ID: 28412434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With the SAPIEN 3 Balloon-Expandable Transcatheter Heart Valve.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
    JACC Cardiovasc Interv; 2016 Feb; 9(3):244-254. PubMed ID: 26847116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings.
    Bagur R; Rodés-Cabau J; Gurvitch R; Dumont É; Velianou JL; Manazzoni J; Toggweiler S; Cheung A; Ye J; Natarajan MK; Bainey KR; DeLarochellière R; Doyle D; Pibarot P; Voisine P; Côté M; Philippon F; Webb JG
    JACC Cardiovasc Interv; 2012 May; 5(5):540-551. PubMed ID: 22625193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The balloon-expandable Edwards Sapien 3 valve is superior to the self-expanding Medtronic CoreValve in patients with severe aortic stenosis undergoing transfemoral aortic valve implantation.
    Gonska B; Seeger J; Baarts J; Rodewald C; Scharnbeck D; Rottbauer W; Wöhrle J
    J Cardiol; 2017 Jun; 69(6):877-882. PubMed ID: 27614379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosthesis depth and conduction disturbances after last generation balloon-expandable transcatheter aortic valve implantation.
    Iacovelli F; Pignatelli A; Giugliano G; Stabile E; Cicala M; Salemme L; Cioppa A; Popusoi G; Pucciarelli A; Verdoliva S; Bortone AS; Losi MA; Coscioni E; Esposito G; Contegiacomo G; Tesorio T
    Europace; 2018 Jan; 20(1):116-123. PubMed ID: 28339584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction recovery and avoidance of permanent pacing after transcatheter aortic valve implantation.
    Marzahn C; Koban C; Seifert M; Isotani A; Neuß M; Hölschermann F; Butter C
    J Cardiol; 2018 Jan; 71(1):101-108. PubMed ID: 28818562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R.
    Kaneko H; Hoelschermann F; Seifert M; Tambor G; Okamoto M; Moeller V; Neuss M; Butter C
    Heart Vessels; 2019 Feb; 34(2):360-367. PubMed ID: 30083944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent Pacemaker Insertion Reduction and Optimized Temporary Pacemaker Management After Contemporary Transcatheter Aortic Valve Implantation With Self-Expanding Valves (from the Pristine TAVI Study).
    Yoon SH; Galo J; Amoah JK; Dallan LAP; Tsushima T; Motairek IK; Rajagopalan V; Hager AM; Galloway BR; Palovich G; Ukaigwe A; Rushing G; Pelletier M; Filby S; Baeza C; Attizzani GF
    Am J Cardiol; 2023 Feb; 189():1-10. PubMed ID: 36481373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pacemaker implantation after TAVI: predictors of AV block persistence.
    Gaede L; Kim WK; Liebetrau C; Dörr O; Sperzel J; Blumenstein J; Berkowitsch A; Walther T; Hamm C; Elsässer A; Nef H; Möllmann H
    Clin Res Cardiol; 2018 Jan; 107(1):60-69. PubMed ID: 28963581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve.
    Watanabe Y; Kozuma K; Hioki H; Kawashima H; Nara Y; Kataoka A; Nagura F; Nakashima M; Shirai S; Tada N; Araki M; Takagi K; Yamanaka F; Yamamoto M; Hayashida K
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2210-2216. PubMed ID: 27832846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Bundle Branch Block after Transcatheter Aortic Valve Implantation with Edwards Sapien 3 Valve: Influence of the Valve Depth Implantation.
    Unzué L; García E; Díaz-Antón B; Rodríguez-Rodrigo FJ; Rodríguez Del Río M; Teijeiro R; Medina J; Parra FJ
    Cardiovasc Revasc Med; 2019 Nov; 20(11):949-955. PubMed ID: 30745060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis.
    Droppa M; Rudolph TK; Baan J; Nielsen NE; Baumgartner H; Vendrik J; Froehlich M; Borst O; Wöhrle J; Gawaz M; Potratz P; Hack LP; Mauri V; Baranowski J; Bramlage P; Kurucova J; Thoenes M; Rottbauer W; Geisler T
    Heart Vessels; 2020 Dec; 35(12):1735-1745. PubMed ID: 32591894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
    Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C
    Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-degree atrioventricular block in patients with preexisting bundle branch block or bundle branch block occurring during transcatheter aortic valve implantation.
    Egger F; Nürnberg M; Rohla M; Weiss TW; Unger G; Smetana P; Geppert A; Gruber SC; Bambazek A; Falkensammer J; Waldenberger FR; Huber K; Freynhofer MK
    Heart Rhythm; 2014 Dec; 11(12):2176-82. PubMed ID: 25034184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.